New clinical guidelines on the diagnosis and management of idiosyncratic drug-induced liver injury (DILI) have now been released. DILI is a rare adverse drug reaction, challenging to diagnose, and can lead to jaundice, liver failure and even death. The frequency of DILI incidence is increasing, as the use of herbal and dietary supplements has drastically increased over the last 10 years.